Cargando…
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
SIMPLE SUMMARY: As a direct consequence of the COVID-19 pandemic, cancer screening programs, management of chronic disease and cancer treatments were either cancelled or delayed. 164 patients with hepatocellular cancer (HCC) were evaluated to understand the impact of the first lockdown on treatment...
Autores principales: | De Souza, Shuell, Kahol de Jong, Jeffrey, Perone, Ylenia, Shetty, Shishir, Qurashi, Maria, Vithayathil, Mathew, Shah, Tahir, Ross, Paul, Temperley, Laura, Yip, Vincent S., Banerjee, Abhirup, Bettinger, Dominik, Sturm, Lukas, Reeves, Helen L., Geh, Daniel, Orr, James, Allen, Benjamin, Jones, Robert P., Sharma, Rohini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341300/ https://www.ncbi.nlm.nih.gov/pubmed/37444488 http://dx.doi.org/10.3390/cancers15133378 |
Ejemplares similares
-
716P Impact of COVID-19 pandemic on clinical outcomes in hepatocellular carcinoma: A multicentre cohort study
por: De Souza, S., et al.
Publicado: (2022) -
The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver
por: Wilkinson, Alex L., et al.
Publicado: (2020) -
Near-Fatal Statin-Associated Autoimmune Myositis
por: Vithayathil, Mathew, et al.
Publicado: (2018) -
Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2023) -
Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
por: Reincke, Marlene, et al.
Publicado: (2022)